The EU Commission is adopting a package of infringement decisions due to the absence of communication by Member States on measures transposing EU directives into national law. Member States concerned have two months to reply to the Commission’s “letters of formal notice” and complete their transposition. Otherwise, the Commission may decide to issue a “reasoned opinion” as next legal step to enforce EU laws.
The legislative package, covering medicinal products for human use, consists of a new directive (adopted with 495 votes in favour, 57 against and 45 abstentions) and regulation (adopted with 488 votes in favour, 67 against and 34 abstentions).
The organisers of the initiative call on the Commission to submit a proposal for financial support to Member States for enabling safe termination of pregnancies for anyone in Europe who lacks access to safe and legal abortion.
The potential for avian influenza viruses to adapt to humans and cause a pandemic remains a concern. Ongoing vigilance, preparedness efforts and an increased understanding of underlying drivers is therefore crucial.
Cardiovascular diseases are the leading cause of premature death in the European Union. Every year there are over 6 million new patients and more than 1.8 million deaths.
Europe’s Beating Cancer Plan is making a real difference to cancer patients and cancer care. Negotiations are on-going to deliver a game-changing reform of the EU’s 20-year-old pharmaceutical legislation. And I was delighted that a political agreement was reached recently between the European Parliament and the European Health Data Space to boost research, empower citizens, and maximise the potential of e-health.
In 2021, the number of businesses in the EU’s health and social work sector amounted to 2.3 million, representing 7.4% of all the enterprises active in the EU’s business economy.
The EU Commission has proposed a series of targeted actions to boost bio-technology and bio-manufacturing in the EU. The Communication on Building the Future with Nature identifies the challenges and barriers and proposes to tackle them.
Three health Team Europe Initiatives (TEIs) were launched today during the high-level event on the European Union (EU) – African Union (AU) partnership on Global Health for equitable access, in Brussels. The TEIs will strengthen health security, support Public Health Institutes in Africa, and boost digital health. On this occasion a Team Europe Initiative on Social Protection was also launched. The Team Europe Initiative on Sustainable Health Security will strengthen
PHSMs refer to non-pharmaceutical measures implemented in community settings to abate the spread of infectious disease. These constituted the primary public health response during the initial phases of the COVID-19 pandemic, notably before medical countermeasures including vaccines became widely available. In future pandemics PHSMs may again be relied upon to reduce disease transmission and mitigate detrimental health impacts.
MEPs adopted their proposals to revamp EU pharmaceutical legislation, to foster innovation and enhance the security of supply, accessibility and affordability of medicines.
The white paper on public health and living conditions in the Sámi population builds on the white paper on Public Health published in 2023. Norway’s general public health policy also applies to the Sámi population. Other important starting points for this white paper were the white paper Escalation Plan for Mental Health (in Norwegian) published last year and the Truth and Reconciliation Commission’s report.
A new Global Consortium for Wastewater and Environmental Surveillance for Public Health (GLOWACON) has been launched today. Its primary objective is to create an international sentinel system for the early detection, prevention, and real-time monitoring of epidemic threats and outbreaks. The launch event is taking place in Brussels over 19-20 March and includes participation of more than 300 key global partners including the European Commission’s HERA, the World Health Organization,
Under the new rules, citizens will have immediate and easy access to their digital health data wherever they are in the EU. Health professionals will be able to access the medical records of a patient when required for treatment in a different Member State, allowing for evidence-based decision making, in full compliance with EU data protection rules. The EHDS also creates a strong legal framework for the re-use of health
The provisional political agreement on a European Health Data Space (EHDS), reached early on Friday by Parliament and the Belgian Presidency of the Council, outlines that patients will be able to access their personal health data electronically across the EU’s different healthcare systems.
Today, the European Commission published its annual report on Safety Gate, the European Rapid Alert System for dangerous non-foods products. The report covers alerts notified in 2023, as well as the corresponding follow-up actions taken by national authorities of the EU Member States, Norway, Iceland, and Liechtenstein. In 2023, cosmetics was the most frequent type of product notified as posing a health risk. Last year marked the highest amount of
Today (6 March) pharmaceutical firm AstraZeneca has outlined plans to invest £650 million in the UK – helping boost the UK’s world leading Life Sciences sector and grow the economy. This significant investment will enhance public health protection and pandemic preparedness.
AstraZeneca intends to invest £450 million at their manufacturing site in Speke, Liverpool for the research, development, and manufacture of vaccines – building on the site’s current
The Finnish Institute for Health and Welfare reported on 29 February that scabies cases have become increasingly common in Finland. On the same day, the Advisory Board on Communicable Diseases, which is appointed by the Government, also discussed at its meeting how to improve the diagnosis and treatment of scabies. The high price of scabies medicines has sparked discussion in Finland. Several medicine packages are needed to treat one family,
In a strong European Health Union, nobody should be left behind, no matter where they live, no matter their disease. Therefore, we need strong EU cooperation to ensure that everyone receives timely diagnosis, as well as affordable treatment and care. For more than 20 years, the EU has made the work in this area a priority. By putting patients at the centre, we have become a pioneer in the fight
Moreover, there has been an increase in the proportion of Escherichia coli isolates from food-producing animals that exhibit ‘complete susceptibility’ or ‘zero resistance’ to key antimicrobials. This, alongside a decrease in the prevalence of E. coli isolates that produce ESBL or AmpC — enzymes which can make some antibiotics ineffective — demonstrates progress in reducing antimicrobial resistance (AMR) in E. coli from food-producing animals across several EU Member States. Mike
MEPs adopt their first reading position about EU supplementary certificates enabling longer protection of patented medicinal and plant protection products. Innovative medicines and pesticides should enjoy 5-year longer EU-wide patent protection on top of 20-year protection of patent to compensate for lengthy testing requirements before these products are placed on the EU market. Unitary supplementary protection certificates aim to cover costs invested into research of innovative substances at the EU
We and use cookies and other tracking technologies to improve your experience on our website. We may store and/or access information on a device and process personal data, such as your IP address and browsing data, for personalised advertising and content, advertising and content measurement, audience research and services development. Additionally, we may utilize precise geolocation data and identification through device scanning.
Please note that your consent will be valid across all our subdomains. You can change or withdraw your consent at any time by clicking the “Consent Preferences” button at the bottom of your screen. We respect your choices and are committed to providing you with a transparent and secure browsing experience.
| Cookie | Duration | Description |
|---|---|---|
| __stripe_mid | This cookie is set by Stripe payment gateway. This cookie is used to enable payment on the website without storing any patment information on a server. | |
| __stripe_sid | This cookie is set by Stripe payment gateway. This cookie is used to enable payment on the website without storing any patment information on a server. | |
| _abck | This cookie is used to detect and defend when a client attempt to replay a cookie.This cookie manages the interaction with online bots and takes the appropriate actions. | |
| _wpfuuid | This cookie is used by the WPForms WordPress plugin. The cookie is used to allows the paid version of the plugin to connect entries by the same user and is used for some additional features like the Form Abandonment addon. | |
| ASP.NET_SessionId | Issued by Microsoft's ASP.NET Application, this cookie stores session data during a user's website visit. | |
| AWSALBCORS | This cookie is managed by Amazon Web Services and is used for load balancing. | |
| bm_sz | This cookie is set by the provider Akamai Bot Manager. This cookie is used to manage the interaction with the online bots. It also helps in fraud preventions | |
| cookielawinfo-checbox-analytics | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". | |
| cookielawinfo-checbox-functional | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". | |
| cookielawinfo-checbox-others | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. | |
| cookielawinfo-checkbox-necessary | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". | |
| cookielawinfo-checkbox-performance | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". | |
| elementor | This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time. | |
| JSESSIONID | Used by sites written in JSP. General purpose platform session cookies that are used to maintain users' state across page requests. | |
| viewed_cookie_policy | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| Cookie | Duration | Description |
|---|---|---|
| _ga | The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors. | |
| _ga_4L7PKQPHHV | This cookie is installed by Google Analytics. | |
| _ga_T50H0MNN9J | This cookie is installed by Google Analytics. | |
| _gat_gtag_UA_12289088_5 | Set by Google to distinguish users. | |
| _gcl_au | Provided by Google Tag Manager to experiment advertisement efficiency of websites using their services. | |
| _gid | Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously. |
| Cookie | Duration | Description |
|---|---|---|
| test_cookie | The test_cookie is set by doubleclick.net and is used to determine if the user's browser supports cookies. |
| Cookie | Duration | Description |
|---|---|---|
| _mcid | No description available. | |
| _swa_u | This cookie is set by the provider Sitewit.com. This cookie is used for statistical report and analysis. | |
| ak_bmsc | No description available. | |
| AWSALB | AWSALB is a cookie generated by the Application load balancer in the Amazon Web Services. It works slightly different from AWSELB. | |
| ec_store_chameleon_font | No description available. | |
| FCCDCF | No description available. | |
| issuem_lp | No description available. | |
| lp_us_his | No description | |
| m | No description available. |